2025
SJR Q3
JCR Q2 · 2,5
40 matched articles
SCIE
Journal detail
Cutis
- Publisher
- Frontline Medical Communications Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0011416223266929
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,276
- Quartile Q3
- H-Index 65
- Cites/doc 0,52
- Docs (3y) 724
- Cites (3y) 394
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,5
- 5Y JIF 2,1
- JCI 0,34
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q3
- Medicine (miscellaneous) Q3
Areas
- Medicine
WoS categories
- Dermatology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q2 | 0,276 | 2,5 | 2,1 | 0,34 | Q4 | 65 |
| 2024 | Q3 | Q2 | 0,281 | 2,7 | 2,1 | 0,38 | Q4 | 62 |
| 2023 | Q3 | Q3 | 0,311 | 2,1 | 1,7 | 0,36 | Q4 | 62 |
| 2022 | Q3 | Q4 | 0,317 | 1,6 | 1,6 | 0,32 | Q4 | 62 |
| 2021 | Q3 | Q4 | 0,294 | 1,7 | 1,5 | 0,32 | Q4 | 62 |
| 2020 | Q3 | Q4 | 0,289 | 1,4 | 1,5 | 0,32 | Q4 | 62 |
| 2019 | Q3 | Q4 | 0,269 | 1 | 1,1 | 0,29 | Q4 | 62 |
| 2018 | — | Q4 | — | 0,6 | 0,9 | 0,29 | Q4 | — |
| 2017 | Q3 | Q4 | 0,393 | 1,2 | 1 | 0,38 | Q4 | 62 |
| 2016 | Q3 | Q3 | 0,278 | 1,2 | 1 | — | — | 62 |
| 2015 | Q3 | Q4 | 0,328 | 0,9 | 0,9 | — | — | 62 |
| 2014 | Q3 | Q4 | 0,331 | 0,7 | 0,8 | — | — | 62 |
| 2013 | Q2 | Q4 | 0,423 | 0,6 | 0,8 | — | — | 62 |
| 2012 | Q2 | Q4 | 0,437 | 0,8 | 0,8 | — | — | 62 |
| 2011 | Q2 | Q4 | 0,529 | 0,8 | 0,9 | — | — | 62 |
| 2010 | Q2 | Q4 | 0,574 | 1 | 1 | — | — | 62 |
| 2009 | — | Q4 | — | 1 | 1 | — | — | — |
| 2008 | — | Q4 | — | 0,8 | 1 | — | — | — |
| 2007 | — | Q4 | — | 0,6 | 0,8 | — | — | — |
| 2006 | — | Q4 | — | 0,9 | — | — | — | — |
| 2005 | — | Q4 | — | 0,9 | — | — | — | — |
| 2004 | — | Q4 | — | 0,8 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q4 | — | 0,5 | — | — | — | — |
| 1998 | — | Q4 | — | 0,5 | — | — | — | — |
| 1997 | — | Q4 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q2 | Q4 | 43/99 |
| 2024 | DERMATOLOGY | SCIE | Q2 | Q4 | 36/96 |
| 2023 | DERMATOLOGY | SCIE | Q3 | Q4 | 48/94 |
| 2022 | DERMATOLOGY | SCIE | Q4 | Q4 | 55/70 |
| 2021 | DERMATOLOGY | SCIE | Q4 | Q4 | 55/69 |
| 2020 | DERMATOLOGY | SCIE | Q4 | Q4 | 61/69 |
| 2019 | DERMATOLOGY | SCIE | Q4 | Q4 | 61/68 |
| 2018 | DERMATOLOGY | SCIE | Q4 | Q4 | 63/66 |
| 2017 | DERMATOLOGY | SCIE | Q4 | Q4 | 53/64 |
| 2016 | DERMATOLOGY | SCIE | Q3 | — | 47/63 |
| 2015 | DERMATOLOGY | SCIE | Q4 | — | 52/61 |
| 2014 | DERMATOLOGY | SCIE | Q4 | — | 56/63 |
| 2013 | DERMATOLOGY | SCIE | Q4 | — | 53/61 |
| 2012 | DERMATOLOGY | SCIE | Q4 | — | 47/59 |
| 2011 | DERMATOLOGY | SCIE | Q4 | — | 48/58 |
| 2010 | DERMATOLOGY | SCIE | Q4 | — | 42/55 |
| 2009 | DERMATOLOGY | SCIE | Q4 | — | 38/48 |
| 2008 | DERMATOLOGY | SCIE | Q4 | — | 39/43 |
| 2007 | DERMATOLOGY | SCIE | Q4 | — | 37/41 |
| 2006 | DERMATOLOGY | SCIE | Q4 | — | 33/39 |
| 2005 | DERMATOLOGY | SCIE | Q4 | — | 31/39 |
| 2004 | DERMATOLOGY | SCIE | Q4 | — | 29/38 |
| 2003 | DERMATOLOGY | SCIE | Q4 | — | 31/38 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 35/40 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 34/38 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 31/36 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 31/36 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 27/35 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 28/32 |